James Edward Eshleman, DO
NPI 1285630889ActiveIndividual· Family Medicine· Calais, ME
Family Medicine (DO) in Calais, Maine, licensed in ME, with an NPI issued in June 2005. Part D covered 2,856 prescriptions written in 2024, 84% of them generic. Astrazeneca Pharmaceuticals LP was the largest of 3 companies reporting payments in 2024, $68.81 in all, mostly food and beverage.
Overview
| NPI | 1285630889 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | DO |
| Sole proprietor | No |
| NPI issued | Jun 28, 2005 |
| Last updated in NPPES | Nov 13, 2019 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Family Medicine Primary | 207Q00000X | 867 | ME |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Family Practice (ME) |
|---|
Part D prescriptions in 2024
| Prescriptions (claims) | 2,856 · 5,746 30-day fills |
|---|---|
| Patients | 311 |
| Total drug cost | $285,857 |
| Generic share | 84% of claims |
Industry payments (Open Payments)
- 2024$68.81 · 4 payments from 3 companies
Top paying companies in 2024
| Company | Amount | Payments |
|---|---|---|
| Astrazeneca Pharmaceuticals LP | $30.71 | 2 |
| Gilead Sciences, Inc. | $20.61 | 1 |
| Abbott Laboratories | $17.49 | 1 |
What the 2024 payments were for
- Food and Beverage$68.81 · 4 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Family Medicine providers in Calais
- 1326134297
- 1962463224
- 1730742107